Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Jan M. Prins"'
Autor:
R J A Diepersloot, W de Bruijn, C van Nieuwkoop, S Nijssen, D Posthouwer, C Jaspers, Jan M. Prins, O Ponteselli, M E van Wolfswinkel, B. M. de Jongh, E B Wilms, Marlies E J L Hulscher, E Mooi, H S A Ammerlaan, B N M Sinha, E Roelofsen, J C Dutilh, C M Verduin, F Snijders, M. M. L. van Rijen, L M Kampschreur, R Brimicombe, M E Sanson, G W D Landman, R Posthuma, M. C. Kallen, C M A Swanink, K R Wilting, R H Streefkerk, P van Hattum, R F J Benus, B Maraha, N Welles, P M G Filius, M Leendertse, C J Miedema, J. W. Van't Wout, P. D. van der Linden, I T M A Overdevest, S U C Sankatsing, T A Ruys, L B S Gelinck, L A Noach, J G den Hollander, S N Bouwman, G J Blaauw, P de Graaf, A Pieffers, R W M A van der Zanden, P Nannan Panday, B J van Dijke, S Teerenstra, M G A van Vonderen, J W Dorigo-Zetsma, P D J Sturm, P C A M Buijtels, D C Melles, E M Kuck, R M T Ladestein, W C van der Zwet, K Hendriks, A Verbon, E H Gisolf, E Nagtegaal, D Huugen, D J Theunissen, Stephanie Natsch, P D Knoester, S W J W Sanders, M.A. Leverstein-van Hall, J L W Pot, N M Delfos, M van den Hurk, Brent C. Opmeer, I van Heijl, E P M van Elzakker, J da Silva-Voorham, M E L Arbouw, K Pogany, J R Lo Ten Foe, M Kuck, A. K. van der Bij, A Muller, F W Sebens, Suzanne E. Geerlings, B Elzer, F. H. Van Tiel
Publikováno v:
Journal of Antimicrobial Chemotherapy, 76, 1625-1632
Journal of Antimicrobial Chemotherapy
The Journal of antimicrobial chemotherapy, 76(6), 1625-1632. Oxford University Press
Journal of Antimicrobial Chemotherapy, 76(6), 1625-1632. Oxford University Press
Journal of Antimicrobial Chemotherapy, 76, 6, pp. 1625-1632
Journal of antimicrobial chemotherapy, 76(6), 1625-1632. Oxford University Press
Journal of Antimicrobial Chemotherapy
The Journal of antimicrobial chemotherapy, 76(6), 1625-1632. Oxford University Press
Journal of Antimicrobial Chemotherapy, 76(6), 1625-1632. Oxford University Press
Journal of Antimicrobial Chemotherapy, 76, 6, pp. 1625-1632
Journal of antimicrobial chemotherapy, 76(6), 1625-1632. Oxford University Press
Background Various metrics of hospital antibiotic use might assist in guiding antimicrobial stewardship (AMS). Objectives To compare patient outcomes in association with three methods to measure and feedback information on hospital antibiotic use whe
Autor:
Jan M. Prins, Judith E. Bosmans, Patricia van Velzen, Gerben ter Riet, Peter J. Sterk, Aureliano Paolo Finch
Publikováno v:
PharmacoEconomics, 37(5), 689-699. Adis International Ltd
Finch, A P, van Velzen, P, Ter Riet, G, Sterk, P J, Prins, J M & Bosmans, J E 2019, ' Doxycycline Added to Prednisolone in Outpatient-Treated Acute Exacerbations of COPD : A Cost-Effectiveness Analysis Alongside a Randomised Controlled Trial ', PharmacoEconomics, vol. 37, no. 5, pp. 689-699 . https://doi.org/10.1007/s40273-018-0756-9
Finch, A P, van Velzen, P, Ter Riet, G, Sterk, P J, Prins, J M & Bosmans, J E 2019, ' Doxycycline Added to Prednisolone in Outpatient-Treated Acute Exacerbations of COPD : A Cost-Effectiveness Analysis Alongside a Randomised Controlled Trial ', PharmacoEconomics, vol. 37, no. 5, pp. 689-699 . https://doi.org/10.1007/s40273-018-0756-9
BACKGROUND: Most patients with mild to severe chronic obstructive pulmonary disease (COPD) experience exacerbations, which are also associated with increased healthcare costs. Despite limited evidence of antibiotics' benefits for exacerbations in out
Autor:
Judith Branger, Willem Joost Wiersinga, Brent C. Opmeer, Robin Soetekouw, Sanjay U. C. Sankatsing, Kees Brinkman, Jan M. Prins, F. N. Lauw, Duncan R Cranendonk, A. I. M. Hoepelman, Jan Veenstra, M.A. van Agtmael, A.H. Pijlman, Jan Jelrik Oosterheert, P. J. de Vries
Publikováno v:
Clinical microbiology and infection, 26(5), 606-612. Elsevier Limited
Cranendonk, D R, Opmeer, B C, van Agtmael, M A, Branger, J, Brinkman, K, Hoepelman, A I M, Lauw, F N, Oosterheert, J J, Pijlman, A H, Sankatsing, S U C, Soetekouw, R, Veenstra, J, de Vries, P J, Prins, J M & Wiersinga, W J 2020, ' Antibiotic treatment for 6 days versus 12 days in patients with severe cellulitis : a multicentre randomized, double-blind, placebo-controlled, non-inferiority trial ', Clinical Microbiology and Infection, vol. 26, no. 5, pp. 606-612 . https://doi.org/10.1016/j.cmi.2019.09.019
Clinical Microbiology and Infection, 26(5), 606-612
Cranendonk, D R, Opmeer, B C, van Agtmael, M A, Branger, J, Brinkman, K, Hoepelman, A I M, Lauw, F N, Oosterheert, J J, Pijlman, A H, Sankatsing, S U C, Soetekouw, R, Veenstra, J, de Vries, P J, Prins, J M & Wiersinga, W J 2020, ' Antibiotic treatment for 6 days versus 12 days in patients with severe cellulitis : a multicentre randomized, double-blind, placebo-controlled, non-inferiority trial ', Clinical Microbiology and Infection, vol. 26, no. 5, pp. 606-612 . https://doi.org/10.1016/j.cmi.2019.09.019
Clinical Microbiology and Infection, 26(5), 606-612
Objectives: To investigate whether antibiotic treatment of 6 days' duration is non-inferior to treatment for 12 days in patients hospitalized for cellulitis. Methods: This multicentre, randomized, double-blind, placebo-controlled, non-inferiority tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08a99dc80bd4061ea8d06ca82566476f
https://pure.amc.nl/en/publications/antibiotic-treatment-for-6-days-versus-12-days-in-patients-with-severe-cellulitis-a-multicentre-randomized-doubleblind-placebocontrolled-noninferiority-trial(a69e4a51-7588-457f-b4df-977e389d3826).html
https://pure.amc.nl/en/publications/antibiotic-treatment-for-6-days-versus-12-days-in-patients-with-severe-cellulitis-a-multicentre-randomized-doubleblind-placebocontrolled-noninferiority-trial(a69e4a51-7588-457f-b4df-977e389d3826).html
Autor:
Jan M. Prins, Maadrika M. N. P. Kanglie, Tjitske S. R. van Engelen, Shandra Bipat, Marcel G. W. Dijkgraaf, Patrick M.M. Bossuyt, Inge A.H. van den Berk, Jaap Stoker
Publikováno v:
Trials
Trials, Vol 21, Iss 1, Pp 1-9 (2020)
Trials, 21(1):407. BioMed Central
Trials, Vol 21, Iss 1, Pp 1-9 (2020)
Trials, 21(1):407. BioMed Central
Background A chest X-ray is a standard imaging procedure in the diagnostic work-up of patients suspected of having non-traumatic pulmonary disease. Compared to a chest X-ray, an ultra-low-dose (ULD) chest computed tomography (CT) scan provides substa
Autor:
Tjitske S. R. van Engelen, Maadrika M. N. P. Kanglie, Jan M. Prins, Patrick M.M. Bossuyt, Wouter de Monyé, Inge A.H. van den Berk, Jaap Stoker, Marcel G. W. Dijkgraaf, Shandra Bipat
Publikováno v:
Diagnostic and Prognostic Research, Vol 2, Iss 1, Pp 1-10 (2018)
Diagnostic and prognostic research, 2
Diagnostic and Prognostic Research, 2:20
Diagnostic and Prognostic Research
Diagnostic and prognostic research, 2
Diagnostic and Prognostic Research, 2:20
Diagnostic and Prognostic Research
Background Chest X-ray has been the standard imaging method for patients suspected of non-traumatic pulmonary disease at the emergency department (ED) for years. Recently, ultra-low-dose chest computed tomography (ULD chest CT) has been introduced, w
Autor:
Olivier Richel, Henry J. C. de Vries, Jan M. Prins, Annina P van Splunter, S. Duin, Guido E.L. van den Berk, Iuliana Ciocanea-Teodorescu, Renske D.M. Steenbergen, Putri W. Novianti, Ramon P. van der Zee, Carel J. M. van Noesel, Wim Quint, Chris J.L.M. Meijer
Publikováno v:
Clinical Infectious Diseases, 68(7), 1110-1117. Oxford University Press
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
van der Zee, R P, Richel, O, van Noesel, C J M, Novianti, P W, Ciocanea-Teodorescu, I, van Splunter, A P, Duin, S, van den Berk, G E L, Meijer, C J L M, Quint, W G V, de Vries, H J C, Prins, J M & Steenbergen, R D M 2019, ' Host Cell Deoxyribonucleic Acid Methylation Markers for the Detection of High-grade Anal Intraepithelial Neoplasia and Anal Cancer ', Clinical Infectious Diseases, vol. 68, no. 7, pp. 1110-1117 . https://doi.org/10.1093/cid/ciy601, https://doi.org/10.1093/cid/ciy601
Clinical infectious diseases, 68(7), 1110-1117. Oxford University Press
Clinical Infectious Diseases, 68, 7, pp. 1110-1117
Clinical Infectious Diseases, 68, 1110-1117
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
van der Zee, R P, Richel, O, van Noesel, C J M, Novianti, P W, Ciocanea-Teodorescu, I, van Splunter, A P, Duin, S, van den Berk, G E L, Meijer, C J L M, Quint, W G V, de Vries, H J C, Prins, J M & Steenbergen, R D M 2019, ' Host Cell Deoxyribonucleic Acid Methylation Markers for the Detection of High-grade Anal Intraepithelial Neoplasia and Anal Cancer ', Clinical Infectious Diseases, vol. 68, no. 7, pp. 1110-1117 . https://doi.org/10.1093/cid/ciy601, https://doi.org/10.1093/cid/ciy601
Clinical infectious diseases, 68(7), 1110-1117. Oxford University Press
Clinical Infectious Diseases, 68, 7, pp. 1110-1117
Clinical Infectious Diseases, 68, 1110-1117
Background High-grade anal intraepithelial neoplasia (AIN2/3; HGAIN) is highly prevalent in human immunodeficiency virus positive (HIV+) men who have sex with men (MSM), but only a minority will eventually progress to cancer. Currently, the cancer ri
Autor:
Marlies E J L Hulscher, Reinier Akkermans, Jan M. Prins, Caroline M. A. van den Bosch, Jan Wille, Suzanne E. Geerlings
Publikováno v:
Journal of antimicrobial chemotherapy, 72(3), 923-932. Oxford University Press
Journal of Antimicrobial Chemotherapy, 72, 923-932
Journal of Antimicrobial Chemotherapy, 72, 3, pp. 923-932
Journal of Antimicrobial Chemotherapy, 72, 923-932
Journal of Antimicrobial Chemotherapy, 72, 3, pp. 923-932
Item does not contain fulltext Objectives: To define appropriate antibiotic use in hospitalized adults treated for a bacterial infection, we previously developed and validated a set of six generic quality indicators (QIs) covering all steps in the pr
Publikováno v:
American journal of clinical dermatology, 19(1), 127-132. Adis International Ltd
American Journal of Clinical Dermatology
American Journal of Clinical Dermatology
Background Available treatment options for anal high-grade squamous intraepithelial lesions (HSIL) in HIV-positive men who have sex with men (MSM) are limited by low response rates and frequent recurrences. Cryotherapy is an established therapeutic o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23fb1a82ecee97542ea11e8b99ff6f4d
https://pure.amc.nl/en/publications/cryotherapy-for-intra-and-perianal-highgrade-squamous-intraepithelial-lesions-in-hivpositive-men-who-have-sex-with-men(1655f1ff-4f1b-4c83-b3db-7e4a8146a16f).html
https://pure.amc.nl/en/publications/cryotherapy-for-intra-and-perianal-highgrade-squamous-intraepithelial-lesions-in-hivpositive-men-who-have-sex-with-men(1655f1ff-4f1b-4c83-b3db-7e4a8146a16f).html
Autor:
José C Beirão, Cláudia N Lang, Ron A. A. Mathôt, Jan M. Prins, Jeannet C. Bos, Ginto Nunguiane, Reinier M. van Hest, Mabor C. Mistício
Publikováno v:
Journal of antimicrobial chemotherapy, 73(6), 1620-1629. Oxford University Press
Background In sub-Saharan Africa (SSA), the highly albumin-bound β-lactam ceftriaxone is frequently used for the empirical treatment of severe bacterial infections. Systemic drug exposure of β-lactams can be altered in critically ill ICU patients,
Autor:
Nening M. Nanlohy, Ingrid M. M. Schellens, Marlous L. Grijsen, Debbie van Baarle, Neeltje A. Kootstra, José A. M. Borghans, Hilde B. Spits, Jan M. Prins, Radjin Steingrover
Publikováno v:
Viral immunology, 28(3), 134-144. Mary Ann Liebert Inc.
The Primo-SHM trial, a multicenter randomized trial comparing no treatment with 24 or 60 weeks of combination antiretroviral therapy (cART) during primary human immunodeficiency virus (HIV) infection (PHI), recently demonstrated that temporary early